stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Return on equity
Calumet, Inc.'s return on equity over the twelve months to 30 June 2026 was 12.7%, up 8.1 percentage points from fiscal 2025 (4.68%). Over the past ten years it has ranged from −136.6% (fiscal 2019) to 228.1% (fiscal 2020); the current reading is higher than 64% of that period. That is above the Specialty Chemicals industry median of 2.34% and above the Basic Materials sector median of 0.00%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 4.68% | (32.21) |
| FY2024 | 36.9% | 46.08 |
| FY2023 | −9.19% | (46.00) |
| FY2022 | 36.8% | (60.02) |
| FY2021 | 96.8% | (131.30) |
| FY2020 | 228.1% | 364.77 |
| FY2019 | −136.6% | (68.72) |
| FY2018 | −67.9% | (2.09) |
| FY2017 | −65.8% | 16.81 |
| FY2016 | −82.6% | (60.01) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| WDFC WD-40 Company compare | 30.4% |
| HWKN Hawkins, Inc. compare | 16.0% |
| AVNT Avient Corporation compare | 15.0% |
| SXT Sensient Technologies Corporation compare | 13.7% |
| CLMT Calumet, Inc. | 12.7% |
| CBT Cabot Corporation compare | 12.2% |
| FUL H. B. Fuller Company compare | 9.58% |
| PRM Perimeter Solutions, SA compare | 4.55% |
| ASH Ashland Inc. compare | 0.00% |
| Specialty Chemicals industry median | 2.34% |
| Basic Materials sector median | 0.00% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement